CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,272,000 | -0.6% | 239,742 | -33.9% | 1.53% | +15.9% |
| Q3 2020 | $6,309,000 | -8.6% | 362,497 | -11.7% | 1.32% | -3.9% |
| Q2 2020 | $6,902,000 | -7.0% | 410,330 | -34.2% | 1.38% | +19.6% |
| Q1 2020 | $7,418,000 | -5.7% | 623,915 | -4.1% | 1.15% | +53.1% |
| Q4 2019 | $7,868,000 | -37.6% | 650,275 | -27.1% | 0.75% | -21.1% |
| Q3 2019 | $12,603,000 | +54.8% | 891,636 | +22.1% | 0.95% | +63.7% |
| Q2 2019 | $8,142,000 | +163.3% | 730,188 | +177.2% | 0.58% | +158.7% |
| Q1 2019 | $3,092,000 | -99.8% | 263,396 | +163.3% | 0.22% | +108.3% |
| Q4 2018 | $1,336,388,000 | +232.4% | 100,029 | +380.2% | 0.11% | +217.6% |
| Q3 2017 | $402,058,000 | +49.5% | 20,832 | -8.6% | 0.03% | +36.0% |
| Q2 2017 | $268,875,000 | -11.0% | 22,786 | -17.3% | 0.02% | -16.7% |
| Q1 2017 | $301,948,000 | – | 27,550 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |